Optimizing Antihypertensive Therapy and Health and Economic Outcomes in a Managed Care Environment

On-Demand Webcast

Jointly sponsored by North American Center for Continuing Medical Education, LLC and Horizon CME

Presenters/Q&A Cohosts

William J. Elliott, MD, PhD
Professor of Preventive Medicine, Internal Medicine,
and Pharmacology
Rush Medical College of Rush University
Rush University Medical Center
Chicago, Illinois

Joel M. Neutel, MD
Associate Professor of Medicine
University of California, Irvine
Director of Research
Orange County Research Center
Tustin, California

Q&A Cohost

Jeffrey D. Dunn, PharmD, MBA
Formulary and Contract Manager
SelectHealth, Inc
Salt Lake City, Utah

Target Audience

This activity is designed for managed markets physicians, pharmacists, and nurses.

Learning Objectives

After completing this activity, participants should be able to:

Differentiate the impact of hypertension on the relative risk of target end-organ damage between diabetic and non-diabetic patients
Discuss the role of combination therapy and the importance of renin-angiotensin-aldosterone system blockade in hypertensive diabetic patients
Identify at least 2 pharmacologic considerations important for achieving and maintaining blood pressure control and adherence to therapy
Describe the health and economic implications of poor adherence to antihypertensive therapy

Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question online post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

There is no fee associated with this activity.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: October 8, 2009

Expiration Date: October 8, 2010

Estimated time to complete: 1 hour

This educational activity is a knowledge-based activity

For questions regarding this educational activity, please contact Angela Scarnici at 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape, or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CME Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of North American Center for Continuing Medical Education, LLC (NACCME) and Horizon CME. NACCME is accredited by the ACCME to provide continuing medical education for physicians.

NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CPE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UAN 276-999-09-009-H01-P).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact John Savage, Director, Medical Education, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535, or by e-mail at jsavage@naccme.com. The Director of Medical Education will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Vice President, Medical Education, NACCME, may be made for a second level of review.

CNE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1.0 contact hour(s). Provider #: 110-3-E-06.

Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 1.0 contact hours.

Independent Clinical Reviewer: Joseph Saseen, PharmD, FCCP, BCPS, CLS, Associate Professor, Department of Clinical Pharmacy, Department of Family Medicine, University of Colorado Denver, School of Pharmacy, Denver, Colorado

Nurse Reviewer: Brenda Barry, RN, BSN, CCM, Clinical Care Coordinator, Clinical Care Management, UNC Hospitals, UNC Health Care Systems, Chapel Hill, North Carolina

Planning Committee

The planning committee comprises Brenda Barry, RN, BSN, CCM, Jeffrey D. Dunn, PharmD, MBA, William J. Elliott, MD, PhD, Joel M. Neutel, MD Joseph Saseen, PharmD, FCCP, BCPS, CLS; Brian Lee, PharmD, Horizon CME; Kristin Dickie, Mary Johnson, Randy Robbin, and John Savage, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME and Lancer Solutions, LLC, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:
Dr. Elliott: Consultant—Gilead Sciences, Inc, Novartis Pharmaceuticals, sanofi-aventis U.S.; Scientific advisor—Gilead Sciences, Inc, Novartis Pharmaceuticals, sanofi-aventis U.S.;Promotional speakers bureau—Forest Pharmacueticals, Pfizer Inc; Other financial support—Elsevier
Dr. Neutel: Consultant—Bristol-Myers Squibb, sanofi-aventis U.S.; Promotional speakers bureau—Boehringer Ingelheim, Bristol-Myers Squibb/Sanofi Pharmacueticals Partnership, Forest Pharmacueticals, Novartis Pharmacueticals, Pfizer, Inc, Sankyo
Dr.Saseen: Consultant—Daiichi Sankyo; Promotional speakers bureau—Daiichi Sankyo
Ms. Barry and Dr. Dunn disclosed no relevant financial relationships with any commercial interests.

Ms. Dickie, Ms. Johnson, Dr. Lee, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed that no off-label/unapproved use(s) of drugs and/or devices will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2009 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership